Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventricular Thrombus

Apixaban versus Warfarin in Patients with Left Ventricular Thrombus: A Pilot Prospective Randomized Outcome Blinded Study Investigating Size Reduction or Resolution of Left Ventricular Thrombus

Background: Treatment of the left ventricular thrombus (LVT) with Vitamin K antagonists (VKAs) such as warfarin may lead to longer hospitalization. Thus, the potential of non-VKA oral anticoagulants as alternative to warfarin need to be explored. This study aims to investigate the size reduction or...

Full description

Bibliographic Details
Main Authors: W Yus Haniff W. Isa, Niny Hwong, Ahmad Khairuddin Mohamed Yusof, Zurkurnai Yusof, Ng Seng Loong, Nadiah Wan-Arfah, Nyi Nyi Naing
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Clinical and Preventive Cardiology
Subjects:
acute myocardial infarction
apixaban
congestive heart failure
echocardiography
left ventricular thrombus
warfarin
Online Access:http://www.jcpconline.org/article.asp?issn=2250-3528;year=2020;volume=9;issue=4;spage=150;epage=154;aulast=W.

Internet

http://www.jcpconline.org/article.asp?issn=2250-3528;year=2020;volume=9;issue=4;spage=150;epage=154;aulast=W.

Similar Items